EON

New Process Shows Patient Recovery May Be Possible

Seattle,WA-One patient that had late stage skin melanoma cancer was successfully treated and is now in remission using an experimental process of treatment.

The process is experimental and controversial, but has shown progress and possible promise for use with other patients across the United States.

The patient was treated by tinkering with his own infection body defenses, using a blood cell therapy that has been examined in the past, but has also been the subject of much controversy.

The new study is being published in this Weeks issue of the New England Journal of Medicine and it talks about using the 30-year-old historical field of the usage of the body’s own defenses to fight cancer and abnormal cell growth.

The process is often referred to as “Adoptive immunotherapy,” and is traced back to the 1980s when it was first used.

Transferring this process from theory to actual usage has been slow. The treatment involves using the patient’s own white blood cells that have been reproduced in a petri dish outside the body, then giving them back to the patient.

It is considered the ultimate in personalized medicine, but it is surrounded with a lot of controversy on both sides.